We have enclosed herewith the monitoring agency report for the quarter ended september 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Apollo Ingredients Ltd (formerly Indsoya Limited) has submitted the quarterly Monitoring Agency Report prepared by Infomerics Valuation and Rating Limited for its Rs. 5.00 crore Rights Issue, which closed in July 2025 (issue period July 16–29, 2025). The issue allotted 1 crore equity shares at Rs. 5 each in a ratio of 25:1. The report confirms zero deviation from stated objects and zero delay in implementation. However, as of September 30, 2025, none of the Rs. 5.00 crore raised has been utilized — the entire amount is parked in an Axis Bank current account. Planned allocation is Rs. 3.65 crore for working capital (pharma/nutraceutical business), Rs. 1.05 crore for general corporate purposes, and Rs. 0.30 crore for issue expenses. The report was reviewed by the Audit Committee and noted by the Board on November 14, 2025.
This is a routine quarterly compliance filing with no negative flags — no deviations, no delays, and no adverse events affecting the issue's objectives. The non-utilization is typical since the rights issue closed only in late July 2025 and deployment was planned across FY26 and FY27. Shareholders should watch subsequent quarterly reports to see actual deployment, especially the Rs. 3.65 crore earmarked for the company's new pharma/nutraceutical business.